WASHINGTON — Last week, LifeSiteNews.com reported that the company manufacturing the abortion drug, RU-486, admitted Monday that there have been five deaths of women who used it. Danco Laboratories refused to admit that there was “any causal relationship” between the women's deaths and their drug, while admitting that the drug was “successful” in its baby-killing mission in over 460,000 cases.
The US Food and Drug Administration (FDA) followed on Tuesday with an announcement that they would be investigating the dangers of the drug while issuing a public health advisory on the risk of sepsis or blood infection when undergoing medical abortion using Mifeprex and misoprostol.
A group of legislators, however, said the FDA's measures were inadequate. After the company revealed the deaths, they called Wednesday for Congress to order a halt to sales of the abortion pill and require further safety review.
“Congress needs to act to take this deadly drug off the market and force a serious review of its safety,” said Senator Jim DeMint (R-SC). Senators Sam Brownback (R-KS)and David Vitter (R-LA) have joined with DeMint to co-sponsor the RU-486 Suspension and Review bill. Congresswoman Melissa Hart (R-PA) is sponsoring companion legislation in the House.
See also:
Abortion Drug Company Boasts That 460,000 American Babies Were Killed in Five Years
Abortion Drug RU-486 Company Admits to Death of Five Women
RU-486 Suspension and Review Act of 2005 (Introduced in Senate)
RU-486 Suspension and Review Act of 2005 (Introduced in House)
(This update courtesy of LifeSiteNews.com.)
